Nanoviricides Stock Fundamentals
| NNVC Stock | USD 1.15 0.01 0.88% |
NanoViricides fundamentals help investors to digest information that contributes to NanoViricides' financial success or failures. It also enables traders to predict the movement of NanoViricides Stock. The fundamental analysis module provides a way to measure NanoViricides' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NanoViricides stock.
At present, NanoViricides' Cost Of Revenue is projected to increase significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 428.5 K, whereas Interest Expense is forecasted to decline to 1,025. NanoViricides | Select Account or Indicator |
NanoViricides Company Return On Equity Analysis
NanoViricides' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current NanoViricides Return On Equity | -0.58 |
Most of NanoViricides' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NanoViricides is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
NanoViricides Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, NanoViricides has a Return On Equity of -0.579. This is 97.58% lower than that of the Biotechnology sector and 98.41% lower than that of the Health Care industry. The return on equity for all United States stocks is 86.77% higher than that of the company.
NanoViricides Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NanoViricides's current stock value. Our valuation model uses many indicators to compare NanoViricides value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NanoViricides competition to find correlations between indicators driving NanoViricides's intrinsic value. More Info.NanoViricides is regarded fifth in return on equity category among related companies. It is rated below average in return on asset category among related companies . At present, NanoViricides' Return On Equity is projected to increase slightly based on the last few years of reporting.Comparative valuation analysis is a catch-all model that can be used if you cannot value NanoViricides by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NanoViricides' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NanoViricides' earnings, one of the primary drivers of an investment's value.NanoViricides Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NanoViricides' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NanoViricides could also be used in its relative valuation, which is a method of valuing NanoViricides by comparing valuation metrics of similar companies.NanoViricides is currently under evaluation in return on equity category among related companies.
NanoViricides Current Valuation Drivers
We derive many important indicators used in calculating different scores of NanoViricides from analyzing NanoViricides' financial statements. These drivers represent accounts that assess NanoViricides' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of NanoViricides' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 42.0M | 50.6M | 21.7M | 13.4M | 15.4M | 14.6M | |
| Enterprise Value | 29.4M | 30.2M | 7.7M | 5.2M | 6.0M | 5.7M |
NanoViricides Fundamentals
| Return On Equity | -0.58 | ||||
| Return On Asset | -0.36 | ||||
| Current Valuation | 8.18 M | ||||
| Shares Outstanding | 11.78 M | ||||
| Shares Owned By Insiders | 4.61 % | ||||
| Shares Owned By Institutions | 10.29 % | ||||
| Number Of Shares Shorted | 98.92 K | ||||
| Price To Earning | (6.02) X | ||||
| Price To Book | 1.18 X | ||||
| EBITDA | (7.84 M) | ||||
| Net Income | (8.59 M) | ||||
| Cash And Equivalents | 14.07 M | ||||
| Cash Per Share | 1.21 X | ||||
| Total Debt | 94.79 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 34.92 X | ||||
| Book Value Per Share | 1.06 X | ||||
| Cash Flow From Operations | (5.67 M) | ||||
| Short Ratio | 3.94 X | ||||
| Earnings Per Share | (0.80) X | ||||
| Target Price | 6.5 | ||||
| Beta | 0.71 | ||||
| Market Capitalization | 13.43 M | ||||
| Total Asset | 16.9 M | ||||
| Retained Earnings | (131.08 M) | ||||
| Working Capital | 7.91 M | ||||
| Current Asset | 24.38 M | ||||
| Current Liabilities | 6.74 M | ||||
| Net Asset | 16.9 M |
About NanoViricides Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NanoViricides's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NanoViricides using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NanoViricides based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 487.2 K | 604.4 K | |
| Total Revenue | 0.00 | 0.00 | |
| Cost Of Revenue | 859.7 K | 902.6 K | |
| Stock Based Compensation To Revenue | 0.00 | 0.00 | |
| Sales General And Administrative To Revenue | 0.00 | 0.00 | |
| Research And Ddevelopement To Revenue | 0.00 | 0.00 | |
| Capex To Revenue | 0.00 | 0.00 | |
| Revenue Per Share | 0.00 | 0.00 | |
| Ebit Per Revenue | 0.00 | 0.00 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NanoViricides in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NanoViricides' short interest history, or implied volatility extrapolated from NanoViricides options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out NanoViricides Piotroski F Score and NanoViricides Altman Z Score analysis. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for NanoViricides Stock analysis
When running NanoViricides' price analysis, check to measure NanoViricides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoViricides is operating at the current time. Most of NanoViricides' value examination focuses on studying past and present price action to predict the probability of NanoViricides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoViricides' price. Additionally, you may evaluate how the addition of NanoViricides to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is NanoViricides' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoViricides. If investors know NanoViricides will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoViricides listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Return On Assets (0.36) | Return On Equity (0.58) |
The market value of NanoViricides is measured differently than its book value, which is the value of NanoViricides that is recorded on the company's balance sheet. Investors also form their own opinion of NanoViricides' value that differs from its market value or its book value, called intrinsic value, which is NanoViricides' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoViricides' market value can be influenced by many factors that don't directly affect NanoViricides' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoViricides' value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoViricides is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoViricides' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.